Skip to content
Navigate to homepage - Cerba Research

About Cerba Research

What we do

Cerba Research is a leading specialty laboratory services provider with the capacity and breadth of a global central laboratory network. Our highly qualified scientists provide insight on the latest biomarkers, assays, and testing approaches and develop innovative solutions for unique challenges across all research phases for pharmaceutical, biotechnology, medical device, government, public health, and CRO organizations.

Cerba Research’s extensive capability in laboratory testing and global logistics, including Bioanalysis, Flow Cytometry, HistoCytopathology, and Next-Generation Sequencing, enables us to drive operational agility at scale in a wide range of therapeutic areas, with recognized expertise in Virology, Immunology, Oncology, and Cell & Gene Therapy.

Cerba Research is part of the Cerba HealthCare Group with 15,000 employees on five continents, driven to advance diagnosis and health.

Our evolution

Specialty
Player

Diversification into new activities & geographies:
Clinical Research – Central Lab Activities

Diversification:
IVD

Diversification into geographies and
Evolution to Precision Medicine

Back to Specialty Roots:
Virology focus – end-to-end logistics

Further diversification into multi-specialist platform, paving the
way to address large international drug development programmes

1967

Cerba Lab

Founding of first Cerba Lab specializing in medical biology

1983

BARC Europe

Founding of BARC Europe, Bio Analytical Research Corporation in Belgium

1996

BARC South Africa

Founding of SA affiliate of BARC in Johannesburg

1997

BARC SA-Lancet JV

Start of the joint venture between BARC SA and Lancet Labs

1999

BARC SA-Lancet JV

Start of the joint venture between BARC SA and Lancet Labs

2001

BARC US

USA affiliate of BARC founded in New York

2007

BARC Acquisition

BARC acquired by Cerba Lab

2009

SRL Medisearch

Start of our long-term partnership with SRL Medisearch in Japan

2018

CerbaLancet JV

Start of Cerba-Lancet Joint Venture in Europe and Africa

Teddy Lab

Start of the long-term partnership with Teddy Lab in China

Histalim

Acquisition of the Histalim specialty lab in France

2019

OWL Metabolomics

Partnership with OWL Metabolomics in Spain

PPC

Start of our long-term partnership with PPC Laboratories in Taiwan

2020

Cerba Research

Barc Lab (BARC), Cerba Xpert and Histalim become Cerba Research

2021

US Expansion

US facility moved to new location & expanded services

CerbACT Asia JV

Start of joint venture with ACT Genomics in Taiwan

2022

Viroclinics-DDL

Cerba & Viroclinics-DDL reach agreement for acquisition

2023

Cirion Biopharma Research

Cerba Research reaches agreement to acquire Cirion

1/18

Our values

Our teams are guided by shared values to Transform Research, Advance Health for You.

EXCELLENCE

We are forever curious, always striving to learn from our collective intelligence, providing assurance that we do better, and go further. We hold ourselves accountable to the highest standards of work and dedicate ourselves to continually achieving exceptional results together.

BOLDNESS

We are resolutely innovative, astute in our risk-taking and unafraid to challenge the status quo for our customers and our people. We dare to take the road less travelled, always looking to transform research with data for the better.

COMMITMENT

In every interaction, we are ambitious and unwavering in our pursuit of the right solution for our clients and their patients. We are committed to our role in driving forward the future of human health.

RESPECT

We value people and relationships and believe in building meaningful long-term partnerships through actively listening and understanding. We are continually mindful of the trust placed in us; every conversation begins with a commitment to transparency and excellence.

Our Mission

Provide innovative laboratory solutions for clinical research to support our customers in bringing improved treatments to patients.

From corporate acquisitions and international expansions to everyday decision-making, one question guides our approach: will this help us serve our customers better?

Contact our experts and find out how we can help you move your clinical trial forward.